Results 71 to 80 of about 9,828 (193)
Oral flecainide is effective in management of refractory tachycardia in infants
Background: Propranolol and digoxin have been used as first line drugs for treatment of supraventricular tachycardia (SVT) in infants. Flecainide and other drugs have been effective as a second line treatment for controlling refractory SVT.
Vikas Kohli
doaj +1 more source
Arrhythmogenic effect of flecainide toxicity [PDF]
Flecainide is a class 1C antiarrhythmic drug especially used for the management ofsupraventricular arrhythmia. In overdose cases, flecainide can induce life treating ventriculararrhythmias and cardiogenic shock.
Bonnefoy, Eric +11 more
core +1 more source
Flecainide Induced Wide Complex Tachycardia
Flecainide can increase QRS duration especially with tachycardia (positive use dependence) and organize atrial fibrillation to atrial ...
Zachariah, Shilla
core
A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks.
Nicolas De Schryver +3 more
doaj +1 more source
Background Vernakalant is authorized in several countries, except in the U.S., where the FDA denied its commercialization due to safety concerns, generating debate about its use.
Giuseppe Dominijanni +5 more
doaj +1 more source
Background: Intravenous (IV) flecainide is recommended for the pharmacological cardioversion of recent-onset atrial fibrillation (AF). The aim of this study was to study the efficacy and safety of IV flecainide, co-administered with oral b-blockers, for ...
Athanasios Kartalis +9 more
doaj +1 more source
Flecainide overdose-induced Brugada electrocardiogram pattern
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with atrial fibrillation and rapid ventricular rate (Figure 1A), which was refractory to her usual combination doses of ‘pill-in-pocket’ metoprolol (25 mg) and
Greaves, K. +20 more
core +1 more source
Background. In the Russian Federation, clinical experience with flecainide remains limited due to its relatively recent regulatory approval. Therefore, it is essential to evaluate the current safety and tolerability of this drug for the prevention of ...
L. V. Polischuk +3 more
doaj +1 more source
Flecainide: long-term treatment using a reduced dosing schedule.
Flecainide was initially prescribed at a dose of 200 mg twice daily, but after early toxicity in patients with ventricular tachycardia (VT), the dosage was reduced to 100 mg twice daily.
Torres, V +4 more
core +1 more source

